Cancer care is rapidly evolving, with precision oncology and immunotherapy transforming outcomes for patients worldwide. Reflecting this progress, Dr. Jyoti Bajpai, Lead – Medical & Precision Oncology at Apollo Hospitals, Navi Mumbai, has been recognized for “Excellence in Precision Oncology” and featured on the cover of a special edition of Femina magazine, recognizing influential women leaders in healthcare. With over 20 years of experience in medical oncology, Dr. Jyoti Bajpai has been instrumental in advancing precision cancer care, delivering personalized treatment approaches for complex and diverse cancer types. A globally recognized researcher and thought leader, she has made significant contributions to precision medicine, immuno-oncology, and equitable cancer care through pioneering research, international collaborations, and scientific publications. Her work continues to combine cutting-edge innovation with compassionate, patient-centred care, helping improve outcomes for cancer patients worldwide. This recognition highlights the importance of clinical innovation, research excellence, and multidisciplinary expertise in shaping the future of oncology. As cancer treatment becomes increasingly personalized, leaders such as Dr. Bajpai are bringing more targeted therapies, improved quality of life, and renewed hope to individuals and families navigating cancer. At Apollo Hospitals, this commitment to advancing evidence-based, patient-first cancer care remains central to delivering better outcomes and transforming lives. 

Strengthening its commitment to accessible, patient-centric healthcare, Apollo Hospitals has launched a new super-speciality centre in Dadar, Mumbai, aimed at improving access to advanced medical care for patients requiring specialised and long-term treatment. The Apollo Super-Speciality Centre offers integrated services across cardiology, neurology, oncology, gastroenterology, orthopaedics, transplantation, and pulmonology, supported by advanced diagnostics, robotics-enabled care, and 24x7 clinical access.  The initiative addresses a significant patient need in Mumbai, where nearly 8,000 patients travel annually to Apollo Hospitals Navi Mumbai for specialised treatment and follow-up care. By bringing expert-led services closer to central Mumbai, the Dadar facility is expected to reduce travel burden by nearly 30 km per visit for many patients, particularly those undergoing cancer treatment, post-transplant recovery, or chronic disease management. The launch was attended by Mr. Arunesh Punetha, Regional CEO – Western Region, along with Apollo experts including Dr. Anil D’Cruz, Director Oncology and Senior Head and Neck Oncology Surgeon; Dr. Deepak Gautam, Senior Consultant Orthopaedic and Robotic Joint Replacement Surgeon; Dr. Dipalee Borade, Consultant Radiation Oncology; Dr. Jyoti Bajpai, Lead Consultant, Medical and Precision Oncology; and Dr. Sumeet Pawar, Consultant Spine and Neurosurgeon, along with members of the community. Speaking at the launch, Dr. Anil D’Cruz highlighted that the expansion reflects Apollo’s focus on ensuring consistent access to trusted specialists, integrated treatment pathways, and continuity of care closer to patients’ homes. The new centre further strengthens Apollo Hospitals’ vision of delivering evidence-based, multidisciplinary healthcare through a connected ecosystem that prioritises patient outcomes, convenience, and long-term wellness. 

Dr. Raj B Singh, Senior Consultant in Respiratory Medicine at Apollo Hospitals, Chennai, has been honoured with a prestigious Lifetime Achievement Award in recognition of his longstanding contributions to pulmonary and respiratory medicine at the Apollo Thoracic Interventions Conference (ATICON) 2026. The recognition celebrates his decades of dedication to advancing respiratory healthcare, medical education, and evidence-based clinical practice.  With decades of experience, Dr. Singh has been instrumental in advancing the diagnosis and treatment of complex respiratory conditions, including asthma, COPD, pleural diseases, and respiratory infections. Widely respected for his clinical expertise and commitment to evidence-based care, he has also contributed significantly to medical research, academic teaching, and professional societies in respiratory medicine. The recognition reflects Dr. Singh’s enduring impact on patient care and medical excellence, while reinforcing Apollo Hospitals’ commitment to fostering clinical leadership, innovation, and globally benchmarked healthcare outcomes. His association with leading professional bodies, including the Indian Chest Society and the British Thoracic Society, reflects his commitment to advancing respiratory medicine globally.   The honour underscores Apollo Hospitals’ continued commitment to clinical excellence, innovation-led healthcare, and nurturing specialists whose work creates a meaningful impact on patient outcomes and the broader healthcare ecosystem.

Apollo Hospitals has launched a dedicated Centre for Venous Disorders at Apollo One, Greams Road, Chennai, aimed at delivering comprehensive and patient-centric care for a wide range of venous conditions. The centre brings together vascular specialists, diagnostic expertise, and advanced minimally invasive treatment approaches to improve long-term patient outcomes.  Senior consultants and vascular surgeons, Dr. Balaji V and Dr. Rajarajan Venkatesan, emphasised the importance of early detection and timely intervention in managing venous diseases effectively. The centre offers advanced diagnosis and treatment for conditions such as varicose veins, deep vein thrombosis (DVT), venous ulcers, and chronic venous insufficiency, with a focus on faster recovery and seamless follow-up care. The launch event was attended by Dr. Ilankumaran Kaliamoorthy, CEO, Apollo Hospitals Chennai Region; Dr. Anil BG, DMS, Apollo Hospitals Cluster 1, Chennai; Mr. Naveen, CEO, Apollo Hospitals, Greams Road, Chennai; along with members of the clinical leadership team, reinforcing Apollo Hospitals’ continued commitment to specialised, innovation-led vascular care.

A 58-year-old woman from Kenya had been living with a failing artificial tricuspid valve since 2011. Over time, the condition caused severe leakage in the valve and weakened the right side of her heart, making even simple activities difficult due to breathlessness. Because another open-heart surgery carried very high risks, several hospitals considered her condition inoperable.  At Indraprastha Apollo Hospitals, New Delhi, Dr. Gautam Naik and team led a groundbreaking transcatheter valve-in-valve procedure, implanting a Sapien Ultra Resilia 29-mm valve inside the failing one without opening the chest. Advanced imaging confirmed immediate resolution of severe leakage, stabilizing her heart function. The days following proved critical: pre-existing weak heart function caused low blood pressure and reduced urine output, requiring intensive care, inotropic support, and meticulous fluid management. Under Dr. Mukesh Goel, Dr. Deepa Sarkar, and the ICU team, her condition stabilized; blood pressure improved, right ventricular function recovered, and urine output normalized. Discharged just six days later in stable condition, she reported less breathlessness at her one-week follow-up and returned home confidently. These catheter-based interventions are vital for high-risk patients, blending compassion with cutting-edge expertise. Apollo's evidence-driven alternatives reduce recovery time and risks, prioritizing outcomes for those unsuitable for open surgery. 

Dr. Yash Gulati, Senior Consultant – Orthopedics & Joint Replacement Surgery at Indraprastha Apollo Hospitals, Delhi, has been honoured with the ‘Best Surgeon of the Year’ award in Joint Replacement at the Six Sigma Healthcare Excellence Awards.  A Padma Shri awardee, Dr. Gulati is known for his work in total hip and knee replacement, minimally invasive arthroscopy, and revision joint replacement procedures. He has also worked extensively in the management of complex orthopedic conditions, including hip disorders associated with sickle cell disease. Over the years, Dr. Gulati has been associated with advancements in computer-navigated and precision-guided joint replacement techniques aimed at improving surgical accuracy and patient outcomes. Apollo Hospitals congratulates Dr. Yash Gulati on the recognition and acknowledges his contribution to the field of orthopedic and joint replacement surgery. 

Advanced imaging and precision interventions strengthen heart care in Northeast India. This is because Apollo Hospitals Guwahati has upgraded its catheterization laboratory (cath lab) with the Philips Azurion 7M20 image-guided therapy system, enhancing its capabilities in advanced cardiac imaging and interventional cardiology. The platform integrates interventional digital X-ray and angiography technology to improve precision, efficiency, and safety during cardiac procedures.  The upgrade was announced at a press meet attended by senior cardiology specialists, including Dr. Rituparna Baruah, Dr. Dibya Jyoti Dutta, Dr. Chandra Kumar Das, and Dr. Chandra Prakash Thakur. The system features advanced 3D imaging and dynamic coronary roadmap technology, enabling clinicians to visualise cardiac structures in real time with greater clarity and accuracy. It is also designed to reduce radiation exposure by up to 60 per cent, supporting safer procedural environments. The enhanced cath lab supports a wide range of minimally invasive procedures such as angioplasty, device implantation, and electrophysiology studies, while strengthening the hospital’s capacity to manage complex cardiac cases and higher procedural volumes. It is expected to enable reduced procedural risks, faster recovery, and improved diagnostic accuracy. Hospital officials noted that the cardiology department performed over 1,500 procedures in the past year, with a mortality rate below 2 per cent. The upgrade is set to further expand access to specialised cardiac care across Northeast India.

Apollo Hospitals Group has expanded its national healthcare footprint with the launch of its 76th hospital: a 400-bed smart hospital in Hyderabad’s Financial District. Designed as a digitally integrated care ecosystem, the hospital brings together advanced clinical capabilities, intelligent workflows, and patient-centric design to enhance care delivery across the continuum. The hospital was formally inaugurated by the Hon’ble Chief Minister of Telangana, Shri Revanth Reddy, in the presence of key dignitaries including Shri Damodar Rajanarsimha, Hon’ble Minister for Health, Medical and Family Welfare, Government of Telangana, and Shri Arekapudi Gandhi, Member of the Telangana Legislative Assembly.  At the core of the hospital is a unified digital platform that enables seamless coordination, supported by AI-driven scheduling and real-time clinical connectivity; reducing delays, improving diagnostic precision, and ensuring continuity of care. Advanced technologies include:  Arthrex Pano Scope for minimally invasive procedures  VALD systems for functional assessment and rehabilitation  uMR Omega 3.0T MRI for faster scan times and enhanced image quality Dedicating the hospital, Dr. Prathap C. Reddy, Founder & Chairman, Apollo Hospitals Group, noted that building a hospital goes beyond infrastructure; it is about creating hope, where compassion, dignity, and clinical excellence come together to serve every patient.  Dr. Sangita Reddy, Joint Managing Director, emphasised that this milestone reflects Apollo’s continued commitment to making quality healthcare accessible to all, integrating advanced technology with its legacy of clinical excellence to strengthen India’s global leadership in healthcare, with Hyderabad emerging as a key hub. Highlighting community impact, Ms. Upasana Konidela, Vice Chairperson – CSR, announced 10,000 free health screenings for the Nanakramguda community, reinforcing Apollo’s focus on preventive care. Mr. Tejesvi Veerepalli, Regional CEO – AP/Telangana, added that integrated emergency systems and connected ambulances will enable faster response during the critical “golden hour,” improving patient outcomes. This launch reflects Apollo’s continued focus on building accessible, technology-enabled healthcare systems; advancing India’s position as a global hub for high-quality medical care. 

Apollo Hospitals, Chennai, has successfully treated a 67-year-old high-risk heart patient using an advanced, minimally invasive procedure called BASILICA-assisted TAVI. This specialised technique is designed to prevent blockage of the coronary artery during valve replacement. This milestone highlights the growing role of advanced transcatheter therapies in managing complex structural heart disease, particularly in patients who are not suitable candidates for repeat open-heart surgery.  The procedure was performed by a multidisciplinary team led by Dr. Sengottuvelu G, Senior Interventional Cardiologist and Clinical Lead of Structural Heart Interventions at Apollo Hospitals Chennai. This approach offers a minimally invasive alternative for redo valve replacement cases, where conventional surgery carries significant risk. The patient had a history of diabetes, coronary artery disease with prior stenting, and aortic valve replacement surgery in 2017. Degeneration of the previous valve led to recurrent aortic stenosis (narrowing) and regurgitation (leakage), both of which can affect blood flow. Before the procedure, a scan revealed a high risk of blockage (an uncommon but serious complication of TAVI), associated with mortality rates of up to 40–50% when it occurs. To reduce this risk, doctors used a combination of TAVI (a catheter-based valve replacement procedure) and the BASILICA technique. In simple terms, BASILICA involves carefully splitting a part of the old valve using controlled energy so that it does not block blood flow to the heart during the new valve placement.   Dr. Sengottuvelu G noted, “This case highlights the evolving capabilities of transcatheter therapies in managing highly complex structural heart disease. BASILICA is a technically demanding procedure, and its successful execution reflects the expertise and coordination of our team.” Dr. C S Muthukumaran, Interventional Cardiologist at Apollo Hospitals Chennai, added, “Performing the first BASILICA procedure in the Apollo Group is a proud moment. It reinforces our commitment to bringing cutting-edge, life-saving technologies to patients in India.” After the procedure, the patient showed good recovery, with improved blood flow, stable rhythm, and no evidence of heart blockage, and was discharged in stable condition. With international success rates exceeding 90% in selected cases, BASILICA remains a highly specialised procedure, underscoring Apollo Hospitals’ commitment to delivering evidence-based, patient-centric cardiac care. 

When a 15-year-old girl from Suriname, South America, developed adolescent idiopathic scoliosis, an abnormal curvature of the spine with no clearly identifiable cause, her family began an urgent global search for specialised care. With limited treatment options in their home country, they reached out to multiple international centres. Apollo Speciality Hospitals, Teynampet, Chennai, responded promptly, enabling a swift consultation and guiding the family’s decision to travel to India for treatment. Dr. Sajan K. Hegde, Director, Spine Surgery, Apollo Speciality Hospitals, and the team, with the 15-year-old patient- Sedi Van Genderen, and her mother - Iris. On arrival, the patient was diagnosed with a severe and rapidly progressing spinal deformity that was affecting posture, mobility, and long-term health. Under the leadership of Dr. Sajan K. Hegde, Director – Spine Surgery, the multidisciplinary team adopted a staged, technology-driven approach. The initial phase involved halo gravity traction over three weeks to gradually improve spinal alignment. This was followed by a two-stage surgical intervention supported by robotic navigation and intraoperative neuromonitoring. In the first surgery, screws were placed into the spine using robotic guidance to ensure high precision. In the second surgery, damaged discs were removed and the spine was stabilised by fusing certain bones together. Finally, the spine was carefully straightened and fixed in place across multiple levels. Robotic systems helped doctors see the spine in real time and place implants with great accuracy, improving outcomes and reducing risks. Following the surgeries, the patient’s spinal curvature was corrected by about 75%, said Dr. Appaji Krishnan, Senior Consultant – Spine Surgery, who emphasised that the outcome was the result of a coordinated multidisciplinary team effort. The patient is recovering well, underscoring the impact of precision-led technologies and expert collaboration in managing complex spinal deformities, and reinforcing Chennai’s position as a trusted global destination for advanced spine care.

 Advanced minimally invasive approach expands treatment options for patients unsuitable for repeat open-heart surgery Chennai, India: Apollo Hospitals, Greams Road, Chennai has successfully treated a high-risk 67-year-old patient with complex heart disease using a rare BASILICA-assisted Transcatheter Aortic Valve Implantation (TAVI) procedure, helping prevent a potentially life-threatening complication during valve replacement.  The advanced minimally invasive procedure was carried out by a multidisciplinary cardiac team led by Dr. Sengottuvelu G, Senior Interventional Cardiologist and the Clinical Lead of Structural Heart Interventions, Apollo Hospitals. This approach is particularly relevant for patients who are not ideal candidates for repeat open-heart surgery, offering a less invasive alternative in complex redo valve cases. The patient presented a complicated medical history, including diabetes, coronary artery disease with prior stent placement, and a previous surgical aortic valve replacement in 2017 for bicuspid aortic stenosis. Over time, the artificial valve deteriorated, leading to severe aortic stenosis and moderate aortic regurgitation, resulting in recurring symptoms and the need for further intervention. Pre-procedure imaging revealed a critical challenge. The coronary arteries, which supply blood to the heart, were located very close to the existing valve. In such cases, placing a new valve can push the valve leaflet into these arteries, potentially blocking blood flow and leading to life-threatening complications. To address this, the team performed a minimally invasive TAVI procedure, where a new valve is delivered through a blood vessel, typically via the leg. Given the high risk of coronary obstruction, this was combined with the BASILICA technique, an advanced method designed to prevent blockage. Dr. Sengottuvelu G, Senior Interventional Cardiologist and Clinical Lead of Structural Heart Interventions, Apollo Hospitals Chennai, said, "This case highlights the evolving capabilities of transcatheter therapies in managing highly complex structural heart disease. BASILICA is a technically demanding procedure, and its successful execution reflects the expertise and coordination of our team." During the procedure, a fine wire was carefully positioned across the valve leaflet that posed the risk. Using a controlled burst of electrical energy, the team precisely split the leaflet. Once divided, the two halves move aside when the new valve is placed, ensuring that blood flow to the coronary arteries is not obstructed. As an added layer of safety, guidewires were placed in both coronary arteries, with backup stents kept ready for immediate use, ensuring that blood flow could be restored instantly if required. Dr. C S Muthukumaran, Interventional Cardiologist, Apollo Hospitals Chennai, added, “Performing the first BASILICA procedure in the Apollo Group is a proud moment. It reinforces our commitment to bringing cutting-edge, life-saving technologies to patients in India.” Following the procedure, the team successfully implanted a transcatheter heart valve, achieving an excellent clinical outcome. The patient showed improved blood flow through the valve, no obstruction to the coronary arteries, stable heart rhythm, and has since been discharged in a stable condition. While coronary artery obstruction during TAVI is rare (occurring in less than 1% of cases), it carries a high mortality risk of up to 40–50%, making prevention critical. Techniques such as BASILICA have been developed globally for such high-risk cases, with success rates exceeding 90% in international studies. However, the procedure remains highly specialised and is not widely performed, particularly in India. This case reflects the growing role of advanced structural heart interventions in managing complex cardiac conditions, while reducing the need for repeat open surgeries and enabling faster recovery for patients.Featuring insights from Dr. Sengottuvelu G, Senior Interventional Cardiologist and Clinical Lead of Structural Heart Interventions, Apollo Hospitals Chennai. And Dr. C S Muthukumaran, Interventional Cardiologist, Apollo Hospitals Chennai 📞 For appointments, call 044 4040 1066

India’s health risks are emerging earlier and often remaining undetected for longer, according to the sixth edition of Apollo Hospitals’ Health of the Nation (HoN) 2026 report, released on World Health Day. Based on over three million preventive health assessments conducted across the Apollo ecosystem in 2025, the report highlights a growing need for proactive and personalised healthcare approaches.  The analysis shows that two in three young adults are already at risk for non-communicable diseases (NCDs). In working populations with an average age of 38, nearly half have prediabetes or diabetes, while eight in ten are overweight. Notably, one in five individuals under 30 is prediabetic, though early intervention has been shown to reverse the condition in many cases. The report also reveals widespread nutritional and fitness concerns, including high rates of Vitamin D and B12 deficiencies and declining physical fitness among younger individuals. Notably, nearly two-thirds of people under 30 assessed showed limitations in strength, flexibility, or balance, early indicators associated with higher long-term risks for cardiovascular disease and reduced physical resilience. Gender-specific insights further highlight risks such as anaemia and the earlier onset of breast cancer, reinforcing the importance of targeted screening and timely preventive care.   Dr. Prathap C. Reddy, Founder Chairman, Apollo Hospitals, emphasised that healthcare must move beyond routine tests to a more personalised and proactive model, where comprehensive health checks help individuals understand long-term risks and take greater ownership of their well-being. Dr. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals, noted that women’s health requires more personalised and life-stage–aligned care, as undetected health conditions can have far-reaching impacts on families, communities, and the broader economy. Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals, highlighted that healthy longevity depends on early and continuous action, with predictive screening and advanced diagnostics playing a key role in identifying diseases such as heart disease and cancer at their earliest, most treatable stages. The report reinforces that structured screening, advanced diagnostics, and follow-up care can significantly improve health outcomes, marking a shift toward predictive, preventive, and personalised healthcare in India.